Patenting Race

Nature Biotechnology, Vol. 24, p. 1349, 2006

3 Pages Posted: 30 Oct 2011

See all articles by Jonathan D. Kahn

Jonathan D. Kahn

Northeastern University - School of Law; Northeastern University - Center for Law, Innovation and Creativity

Date Written: January 1, 2006

Abstract

As genetic databases continue to yield new insights and inventions, the commercial incentive to conflate race and genetics may be hard to resist. This article discusses the move to use race as a genetic category to obtain patent protection and drug approval. The article does not attempt to present a definitive characterization of the meaning of race and/or ethnicity, but is concerned more with how these terms are being invoked in biotech patents.

Keywords: Medicine, drug, race, ethnicity, African Americans, BiDil, heart failure, genetics, patents

Suggested Citation

Kahn, Jonathan D., Patenting Race (January 1, 2006). Nature Biotechnology, Vol. 24, p. 1349, 2006, Available at SSRN: https://ssrn.com/abstract=1950404

Jonathan D. Kahn (Contact Author)

Northeastern University - School of Law ( email )

416 Huntington Avenue
Boston, MA 02115
United States

Northeastern University - Center for Law, Innovation and Creativity

416 Huntington Avenue
Boston, MA 02115
United States

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
40
Abstract Views
1,150
PlumX Metrics